Abstract: A sample container holding mechanism is for holding a sample container 6, and includes a hook member 9 and a stopper member 10. The hook member 9 suspends and holds the sample container 6 in a state where the sample container 6 is inclined with respect to a vertical direction. The stopper member 10 restricts the rotation of the sample container 6 when the sample container 6 is rotated around the hook member 9.

Abstract: The present invention relates to saturated-ring-fused dihydropyrimidinone or dihydrotriazinone compounds, or pharmaceutically acceptable salts having ROR? antagonist activity, pharmaceutical compositions comprising the same, and pharmaceutical use thereof. A compound of Formula [I] or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the same, and pharmaceutical use thereof are provided: wherein each substituent is defined as defined in the description.

Abstract: A compound of Formula [I] or a pharmaceutically acceptable salt thereof: wherein each symbol is defined as in the specification.

Abstract: A mass spectrometer includes: a probe having an electric conductivity; a probe moving unit configured to move the probe; a high voltage application unit configured to apply a high voltage to the probe located at an ion generation position where the tip of the probe is apart from the sample, so as to generate an ion from the sample adhered to the probe, the ion originating from a component in the sample; and a sample holding unit that includes a sample holder having a plurality of concave portions, each configured to hold the sample, and a base configured to hold the sample holder in a removable manner, the base including a mechanical element configured to move the sample holder in order to sequentially move each of the plurality of concave portions of the sample holder to the sample collection position.

Abstract: The other end of an individual sample supply channel one end of which is connected to a gas buffer container the inside of which is empty is connected to one sub-port of a valve that selects one of standard samples to be supplied to an ESI probe. During analysis, the standard sample stored in one of liquid sample containers is selected by switching a connection state of the valve. The standard sample supplied by being pushed by a gas sent to the liquid sample containers through liquid supply gas branch channels is sent to the ESI probe through a sample supply main channel. At the time of finishing analysis, when the valve is switched such that the sub-port and a main port are communicatively connected, a nitrogen gas is sent to the sample supply main channel, and the remaining liquid is discharged.

Abstract: The other end of an individual sample supply channel one end of which is connected to a gas buffer container the inside of which is empty is connected to one sub-port of a valve that selects one of standard samples to be supplied to an ESI probe. During analysis, the standard sample stored in one of liquid sample containers is selected by switching a connection state of the valve. The standard sample supplied by being pushed by a gas sent to the liquid sample containers through liquid supply gas branch channels is sent to the ESI probe through a sample supply main channel. At the time of finishing analysis, when the valve is switched such that the sub-port and a main port are communicatively connected, a nitrogen gas is sent to the sample supply main channel, and the remaining liquid is discharged.

Abstract: The present invention relates to saturated-ring-fused dihydropyrimidinone or dihydrotriazinone compounds, or pharmaceutically acceptable salts having ROR? antagonist activity, pharmaceutical compositions comprising the same, and pharmaceutical use thereof. A compound of Formula [I] or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the same, and pharmaceutical use thereof are provided: wherein each substituent is defined as defined in the description.

Abstract: The other end of an individual sample supply channel one end of which is connected to a gas buffer container the inside of which is empty is connected to one sub-port of a valve that selects one of standard samples to be supplied to an ESI probe. During analysis, the standard sample stored in one of liquid sample containers is selected by switching a connection state of the valve. The standard sample supplied by being pushed by a gas sent to the liquid sample containers through liquid supply gas branch channels is sent to the ESI probe through a sample supply main channel. At the time of finishing analysis, when the valve is switched such that the sub-port and a main port are communicatively connected, a nitrogen gas is sent to the sample supply main channel, and the remaining liquid is discharged.

Abstract: The other end of an individual sample supply channel one end of which is connected to a gas buffer container the inside of which is empty is connected to one sub-port of a valve that selects one of standard samples to be supplied to an ESI probe. During analysis, the standard sample stored in one of liquid sample containers is selected by switching a connection state of the valve. The standard sample supplied by being pushed by a gas sent to the liquid sample containers through liquid supply gas branch channels is sent to the ESI probe through a sample supply main channel. At the time of finishing analysis, when the valve is switched such that the sub-port and a main port are communicatively connected, a nitrogen gas is sent to the sample supply main channel, and the remaining liquid is discharged.

Abstract: A compound of Formula [I] or a pharmaceutically acceptable salt thereof: wherein each symbol is defined as in the specification.

Abstract: A sample container holding mechanism is for holding a sample container 6, and includes a hook member 9 and a stopper member 10. The hook member 9 suspends and holds the sample container 6 in a state where the sample container 6 is inclined with respect to a vertical direction. The stopper member 10 restricts the rotation of the sample container 6 when the sample container 6 is rotated around the hook member 9.

Abstract: A lid member 24 of a valve device 6 is detachably attached to a main body housing 21 fixed to a casing 5. A connection pipe is attached to the lid member 24. A pipe fitting 40 is connected to a pipe fixed to the casing 5. When the lid member 24 is mounted to the main body housing 21, the connection pipe is inserted in the pipe fitting 40 connected to the pipe 11. Thus, the lid member 24 can be mounted to the main body housing 21, with the lid member disposed at a fixed position relative to the main body housing 21. When the lid member 24 is detached from the main body housing 21, the connection pipe 25 is separated from the internal of the pipe fitting 40, and thus, the pipe 11 connected to the pipe fitting 40 does not move together with the lid member 24, and is maintained to be disposed at the fixed position in the casing 5. As a result, the pipe 11 can be prevented from hindering operation of an operator.

Abstract: A compound of Formula [I] or a pharmaceutically acceptable salt thereof: wherein each symbol is defined as in the specification.

Abstract: The present invention relates to saturated-ring-fused dihydropyrimidinone or dihydrotriazinone compounds, or pharmaceutically acceptable salts thereof, having ROR? antagonist activity, pharmaceutical compositions comprising the same, and pharmaceutical use thereof. A compound of Formula [I] or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the same, and pharmaceutical use thereof are provided: wherein each substituent is defined as defined in the description.

Abstract: A lid member 24 of a valve device 6 is detachably attached to a main body housing 21 fixed to a casing 5. A connection pipe is attached to the lid member 24. A pipe fitting 40 is connected to a pipe fixed to the casing 5. When the lid member 24 is mounted to the main body housing 21, the connection pipe is inserted in the pipe fitting 40 connected to the pipe 11. Thus, the lid member 24 can be mounted to the main body housing 21, with the lid member disposed at a fixed position relative to the main body housing 21. When the lid member 24 is detached from the main body housing 21, the connection pipe 25 is separated from the internal of the pipe fitting 40, and thus, the pipe 11 connected to the pipe fitting 40 does not move together with the lid member 24, and is maintained to be disposed at the fixed position in the casing 5. As a result, the pipe 11 can be prevented from hindering operation of an operator.

Abstract: A compound of Formula [I] or a pharmaceutically acceptable salt thereof: wherein each symbol is defined as in the specification.

Abstract: A work vehicle includes two types of PTO shafts, a PTO drive unit, a storage unit, a PTO gear shift operation unit, a PTO shaft detection sensor, a PTO gear shift sensor and a control device. The storage unit stores a PTO shaft, which is not connected to the driven portion, of the two types of PTO shafts. The PTO gear shift operation unit performs gear-shifting of the gear shift mechanism. The PTO shaft detection sensor detects a type of the PTO shaft stored in the storage unit. The PTO gear shift sensor detects an operation state of the PTO gear shift operation unit. The control device decides a propriety of a combination of a detection value of the PTO shaft detection sensor and a detection value of the PTO gear shift sensor.

Abstract: A work vehicle includes two types of PTO shafts, a PTO drive unit, a storage unit, a PTO gear shift operation unit, a PTO shaft detection sensor, a PTO gear shift sensor and a control device. The storage unit stores a PTO shaft, which is not connected to the driven portion, of the two types of PTO shafts. The PTO gear shift operation unit performs gear-shifting of the gear shift mechanism. The PTO shaft detection sensor detects a type of the PTO shaft stored in the storage unit. The PTO gear shift sensor detects an operation state of the PTO gear shift operation unit. The control device decides a propriety of a combination of a detection value of the PTO shaft detection sensor and a detection value of the PTO gear shift sensor.

Abstract: A compound of Formula [I] or a pharmaceutically acceptable salt thereof: wherein each symbol is defined as in the specification.